Please sign in to follow a disease.
NICU staff survey reveals how End-of-Life decisions are made for newborns
NCT ID NCT03368248
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study surveyed doctors and nurses in Paris-area newborn intensive care units (NICUs) to understand how they make decisions about end-of-life care, including when to stop life support. The goal was to see how well staff are trained in palliative care and how they involve parents in these difficult choices. The study did not test a new treatment but rather gathered information on current practices.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
61 people
The number who actually took part.
- Started
-
Jan 2016
- Finished
-
Apr 2016
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Medico-caring staff of the NICUs in the Paris region.
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * medico-caring staff of the NICUs in the Paris region Exclusion Criteria: * No response to the supplementary questionnaire, not allowing to assess the response rate of the center
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Neonatal death are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital NOVO
Cergy-Pontoise, 95300, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.